Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COM Direxion Auspice Broad Commodity Strategy ETF	$27.79 -0.3%	$27.97	$27.46 ▼ $29.63	$180.64M	0.19	57,019 shs	18,802 shs
IBT IBEX Technologies	C$1.44	C$1.44	C$0.75 ▼ C$1.45	C$35.54M	-0.05	68,888 shs	200 shs
ONC BeOne Medicines	$308.91 +0.1%	$281.26	$170.99 ▼ $330.63	$33.86B	0.27	428,569 shs	120,362 shs
SCYB Schwab High Yield Bond ETF	$26.59 +0.1%	$26.39	$24.73 ▼ $26.79	$1.28B	0.33	480,469 shs	615,860 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COM Direxion Auspice Broad Commodity Strategy ETF	+0.07%	+0.98%	-1.35%	-1.73%	-3.18%
IBT IBEX Technologies	0.00%	0.00%	0.00%	0.00%	0.00%
ONC BeOne Medicines	-1.61%	-3.35%	+5.89%	+29.51%	+30,862,999,900.00%
SCYB Schwab High Yield Bond ETF	-0.11%	+0.42%	+0.26%	+1.53%	+0.38%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IBT IBEX Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONC BeOne Medicines	0.5674 of 5 stars	1.5	0.0	0.0	0.0	1.4	1.7	0.6
SCYB Schwab High Yield Bond ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COM Direxion Auspice Broad Commodity Strategy ETF	0.00	N/A	N/A	N/A
IBT IBEX Technologies	0.00	N/A	N/A	N/A
ONC BeOne Medicines	3.00	Buy	$330.89	7.11% Upside
SCYB Schwab High Yield Bond ETF	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest IBT, ONC, SCYB, and COM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/7/2025	ONC BeOne Medicines	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$349.00 ➝ $364.00
8/7/2025	ONC BeOne Medicines	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$350.00 ➝ $365.00
7/17/2025	ONC BeOne Medicines	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$321.00 ➝ $345.00
7/16/2025	ONC BeOne Medicines	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$311.00 ➝ $349.00
6/27/2025	ONC BeOne Medicines	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$313.00 ➝ $330.00
6/27/2025	ONC BeOne Medicines	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$317.00 ➝ $321.00
6/27/2025	ONC BeOne Medicines	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Outperform ➝ Moderate Buy	$311.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	N/A	N/A	N/A	N/A
IBT IBEX Technologies	C$5.77M	6.15	C$0.92 per share	1.56	C$0.58 per share	2.48
ONC BeOne Medicines	$4.56B	7.42	N/A	N/A	$34.10 per share	9.06
SCYB Schwab High Yield Bond ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
IBT IBEX Technologies	C$3.10M	C$0.12	11.52	∞	N/A	53.78%	21.95%	6.42%	N/A
ONC BeOne Medicines	-$644.79M	-$1.73	N/A	435.08	N/A	-3.89%	-1.22%	-0.72%	N/A
SCYB Schwab High Yield Bond ETF	N/A	N/A	60.28	∞	N/A	N/A	N/A	N/A	N/A

Latest IBT, ONC, SCYB, and COM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2025	Q2 2025	ONC BeOne Medicines	$0.48	$0.84	+$0.36	$0.84	$1.24 billion	$1.32 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COM Direxion Auspice Broad Commodity Strategy ETF	$0.99	3.56%	N/A	N/A	N/A
IBT IBEX Technologies	N/A	3.11%	N/A	N/A	N/A
ONC BeOne Medicines	N/A	N/A	N/A	N/A	N/A
SCYB Schwab High Yield Bond ETF	$1.86	7.00%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	N/A
IBT IBEX Technologies	11.06	6.24	4.93
ONC BeOne Medicines	0.04	1.95	1.72
SCYB Schwab High Yield Bond ETF	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COM Direxion Auspice Broad Commodity Strategy ETF	N/A
IBT IBEX Technologies	19.05%
ONC BeOne Medicines	48.55%
SCYB Schwab High Yield Bond ETF	N/A

Insider Ownership

Company	Insider Ownership
COM Direxion Auspice Broad Commodity Strategy ETF	N/A
IBT IBEX Technologies	25.36%
ONC BeOne Medicines	6.62%
SCYB Schwab High Yield Bond ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	6.50 million	N/A	Not Optionable
IBT IBEX Technologies	N/A	24.68 million	N/A	Not Optionable
ONC BeOne Medicines	11,000	109.60 million	102.34 million	N/A
SCYB Schwab High Yield Bond ETF	N/A	48.30 million	N/A	Not Optionable

IBT, ONC, SCYB, and COM Headlines

Recent News About These Companies

CSE Bulletin: Consolidation - Scryb Inc. (SCYB)

August 11, 2025 | newsfilecorp.comN

SCYB: Passive High Yield ETF From Schwab

July 16, 2025 | seekingalpha.com

Schwab High Yield Bond ETF declares $0.1527 dividend

July 1, 2025 | msn.com

7 Lowest Expense Ratio ETFs

June 10, 2025 | money.usnews.com

SCYB: Not The Time For High Yield

May 4, 2025 | seekingalpha.com

Schwab High Yield Bond ETF declares $0.1586 dividend

May 2, 2025 | seekingalpha.com

Schwab High Yield Bond ETF (SCYB) Dividend History

March 29, 2025 | nasdaq.com

Trend Tracker for (SCYB)

February 11, 2025 | news.stocktradersdaily.comN

(SCYB) Trading Signals

January 31, 2025 | news.stocktradersdaily.comN

These High-Yield Dividend Stocks Are Looking Better Than Bonds for Safety

January 27, 2025 | msn.com

When the Price of (SCYB) Talks, People Listen

January 20, 2025 | news.stocktradersdaily.comN

(SCYB) Investment Report

December 30, 2024 | news.stocktradersdaily.comN

When (SCYB) Moves Investors should Listen

December 19, 2024 | news.stocktradersdaily.comN

Schwab High Yield Bond ETF declares monthly distribution of $0.1489

December 3, 2024 | msn.com

(SCYB) Proactive Strategies

November 17, 2024 | news.stocktradersdaily.comN

Schwab High Yield Bond ETF declares monthly distribution of $0.1667

November 5, 2024 | msn.com

(SCYB) Long Term Investment Analysis

October 17, 2024 | news.stocktradersdaily.comN

Where are the Opportunities in (SCYB)

September 15, 2024 | news.stocktradersdaily.comN

Schwab High Yield Bond ETF declares monthly distribution of $0.3075

September 4, 2024 | msn.com

SCHO: A Low-Risk, High-Yield Pick To Boost Your Dividend Portfolio's Stability

August 29, 2024 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IBT, ONC, SCYB, and COM Company Descriptions

Direxion Auspice Broad Commodity Strategy ETF NYSEARCA:COM

$27.79 -0.08 (-0.29%)

Closing price 04:10 PM Eastern

Extended Trading

$27.79 0.00 (0.00%)

As of 04:10 PM Eastern

The Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.

IBEX Technologies CVE:IBT

C$1.44 0.00 (0.00%)

As of 04/5/2024

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

BeOne Medicines NASDAQ:ONC

$308.91 +0.28 (+0.09%)

As of 04:00 PM Eastern

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Schwab High Yield Bond ETF NYSEARCA:SCYB

$26.59 +0.03 (+0.11%)

Closing price 04:10 PM Eastern

Extended Trading

$26.59 0.00 (0.00%)

As of 06:47 PM Eastern

The Schwab High Yield Bond ETF (SCYB) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks an index of USD-denominated high-yield, US corporate bonds, selected and weighted based on market value. SCYB was launched on Jul 11, 2023 and is managed by Charles Schwab.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time